About the Product

Description


Isofyle 60 Tablet containing Isosorbide Mononitrate is used for the prevention and management of angina pectoris. It helps in improving blood circulation and reducing the workload on the heart.

Isosorbide Mononitrate works by relaxing and widening blood vessels, which improves oxygen supply to the heart muscles and helps prevent chest pain episodes effectively.

The tablet is widely prescribed in cardiology practice for long-term management of angina and related cardiac conditions, leading to consistent demand and repeat usage.

With increasing prevalence of cardiovascular disorders and growing demand for long-term cardiac therapies, this product offers strong business potential for retailers and distributors. Its steady prescription demand, chronic therapy usage, and broad clinical acceptance make it a reliable product for consistent sales and growth in the cardiac segment.

Some patients may experience headache, dizziness, flushing, low blood pressure, or nausea. Rarely, fainting or severe hypotension may occur and require medical attention.

Isofyle 60 Tablet is indicated for the prevention and long-term management of angina pectoris. It helps reduce the frequency and severity of chest pain attacks, improve exercise tolerance, and support better cardiovascular performance.

This medicine should be used under medical supervision. Sudden discontinuation should be avoided. Patients should rise slowly from sitting or lying positions to reduce dizziness. It should not be used with phosphodiesterase inhibitors such as Sildenafil due to the risk of severe blood pressure drop.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Isofyle 60 Tablet in the PCD pharma franchise market?

What are the business opportunities for Isofyle 60 Tablet in the PCD pharma franchise market?

Why should medical distributors include Isofyle 60 Tablet in their product range?

Medical distributors and agencies can benefit from the consistent demand for higher-dose nitrate therapy used in angina pectoris, coronary artery disease, and long-term heart failure management. Isofyle 60 Tablet helps strengthen a comprehensive cardiology product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Isofyle 60 Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Isofyle 60 Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Isofyle 60 Tablet distribution?

Wholesalers and medical agencies benefit from strong cardiac prescription demand, reliable availability, business margins, and professional support when partnering for Isofyle 60 Tablet distribution.

How can I become a distributor or franchise partner for Isofyle 60 Tablet?

Medical distributors, stockists, and wholesalers interested in Isofyle 60 Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.